Impilo Partners AB

636700D3LX69IP4P3705

This company holds an LEI

The code is maintained by another issuer. Moving it to us is free, and the annual fee is the same as everyone pays.

Issued today byNordLEI

559168-5937 · See the company record

The entity

Status: Active
LEI status: Issued and current
Category: Company
Legal form: Aktiebolag (XJHM)
Jurisdiction: Sweden
Entity created: August 21, 2018

Address

Country: Sweden
Legal address: Box 3296103 65 StockholmSweden (SE-AB)

Identifier

LEI: 636700D3LX69IP4P3705
Registered: April 12, 2023 at 07:38 AM UTC
Last updated: February 16, 2026 at 06:27 AM UTC
Next renewal: April 14, 2027 at 05:51 AM UTC
Issuer: NordLEI (549300O897ZC5H7CY412)
Registered with: Companies Register (RA000544)
Identifier: 559168-5937
Verified against: Companies Register (RA000544)
Verified as: 559168-5937
Corroboration: Confirmed against a public register
GLEIF conformity: Meets the standard

Corporate structure

Owns7

Immedica Pharma AB
Held through a subsidiarySweden
Impilo Holding AB
Direct subsidiarySweden
Impilo Industrial Partners (No. 1) AB
Direct subsidiarySweden
Impilo Management (No. 1) AB
Direct subsidiarySweden
Impilo Management (No. 2) AB
Direct subsidiarySweden
Impilo Management (No.3) AB
Direct subsidiarySweden
ULT Denmark ApS
Held through a subsidiaryDenmark

Why no parent is reported

No direct parent reportedNo ultimate parent reported: The parent is one or more private individuals

Machine access

REST: https://lei.online/v1/entities/636700D3LX69IP4P3705This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search